Airing frustrations with pharma, a Republican FTC commissioner just endorsed Medicare negotiation

16 January 2020 - A Republican member of the Federal Trade Commission on Thursday expressed support for allowing Medicare to ...

Read more →

Pricing of pharmaceuticals is becoming a major challenge for health systems

13 January 2020 - Manufacturers using their market power to maximise profits results in prices that are unjustifiable and unaffordable. ...

Read more →

Defining the concept of fair pricing for medicines

13 January 2020 - Suerie Moon and colleagues consider what makes a fair price for both buyers and sellers. ...

Read more →

BioMarin explores pricing experimental gene therapy at $2 million to $3 million

16 January 2020 - Valrox would be first gene therapy approved in U.S. for inherited type of haemophilia. ...

Read more →

EQRX wants to make high-end medicines less costly

17 January 2020 - A Boston-based biotech startup thinks it has found a lucrative third way between high-margin branded drugs and ...

Read more →

Pharma execs pitch ideas at JPM20 to lower drug costs. None of them include dropping their own prices.

16 January 2020 - CEOs from the world’s largest pharmaceutical companies pitched ideas for lowering drug prices at the J.P. Morgan ...

Read more →

U.S. targets drug pricing, no-poach deals for anti-trust action in 2020

15 January 2020 - Justice Department antitrust chief also promises decision on music licensing, criticizes states’ lawsuit against T-Mobile and Sprint. ...

Read more →

Prices of MS medications keep soaring

15 January 2020 - The cost of essential medications for multiple sclerosis have nearly tripled this decade, despite the release ...

Read more →

Democrats zero in on high drug prices in Iowa debate

14 January 2020 - Until Tuesday, nearly every single Democratic primary debate has focused on the same health care issue: ...

Read more →

Roche aims to 'underwhelm' on SMA drug price to challenge rivals

14 January 2020 - Swiss drug maker Roche plans to price its oral spinal muscular atrophy drug risdiplam aggressively to challenge ...

Read more →

High cost of multiple sclerosis medicines is forcing many patients to take ‘drastic actions’

13 January 2020 - The high cost of multiple sclerosis treatments has forced 40% of patients to take “drastic actions” ...

Read more →

Drug makers test new ways to pay for six figure treatments

13 January 2020 - Public pressure, insurer pushback and better data are driving drug companies to tinker with how they get ...

Read more →

The Tories must learn from the Orkambi victory and keep drug-pricing off the table

12 January 2020 - To match its rhetoric on the NHS, the government has to legally commit to preventing drug-pricing being ...

Read more →

Start-up proposes ‘third way’ to cut US drug prices

12 January 2020 - Alexis Borisy secures $200 million funding for venture aiming to use ‘fast follow’ treatments. ...

Read more →

Lies, damn lies, and drug price increases

9 January 2020 - As each new year begins, drug manufacturers announce their changes to the list price of drugs.  ...

Read more →